Invitation to presentation in connection with EQL Pharma's interim report, third quarter, 2024/25

EQL Pharma AB (publ) will publish its interim report for the third quarter, 2024/25, on Wednesday, February 5^th, before stock markets opening.

At 10.00 (CET) 5^th February, the company will give a presentation via video conference. The presentation is aimed at shareholders and potential shareholders. CEO and President Axel Schörling presents and comments on the interim report. After the presentation, there is an opportunity to ask questions for those who participate.

Use the following link to access the virtual meeting: https://tinyurl.com/3w35ae8k

Date and time

February 5^th, 2025, at 10.00 (CET) the presentation starts. Time required for presentation and subsequent question time is estimated at a maximum 1 hour.

Make sure you are able to attend the video conference by logging in shortly before the start of the conference.